Zoplar, a platform revolutionizing the medical equipment procurement process for small and medium-sized hospitals, has secured $3.4 million in a Series A funding round led by Blume Ventures. The round also included investments from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX.
With this round, Zoplar’s total funding stands at $5.1 million, backed by Titan Capital, Stride Ventures, and Panthera Peak.
The new funds will be used to enhance operational efficiency, focusing on backward supply chain integration and building a strong service engineering team, according to the company.
Founded in 2022 by Amit Sah and Umesh Sharma, Zoplar offers a comprehensive medical equipment platform addressing critical challenges faced by MSME hospitals. These include finding cost-effective products, managing vendor relationships, ensuring reliable after-sales service, and accessing financing solutions.
Zoplar has partnered with around 300 hospitals, including leading nephrology chains like DCDC, and boasts a 40% repeat customer rate, highlighting the growing demand for quality medical equipment in the healthcare sector.
